BIOMARKER-DRIVEN STRATIFICATION OF DISEASE-RISK IN NON-METASTATIC MEDULLOBLASTOMA: THE SIOP-EUROPE PNET4 CLINICAL TRIAL

被引：0
|
作者：
Clifford, Steven [2 ]
Gustafsson, Goran [1 ]
Ellison, David [3 ]
Figarella-Branger, Dominique [4 ]
Doz, Francois [5 ]
Rutkowski, Stefan [6 ]
Lannering, Birgitta [1 ]
Pietsch, Torsten [7 ]
机构：
[1] Univ Gothenburg, Gothenburg, Sweden
[2] Newcastle Univ, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England
[3] St Jude Childrens Res Hosp, Memphis, TN 38105 USA
[4] Hop Enfants La Timone, Marseille, France
[5] Inst Curie, Paris, France
[6] Univ Med Ctr Hamburg Eppendorf, Hamburg, Germany
[7] Univ Bonn, Bonn, Germany
来源：
NEURO-ONCOLOGY | 2012年 / 14卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：85 / 85
页数：1
相关论文
共 18 条
  • [1] BIOMARKER-DRIVEN STRATIFICATION OF DISEASE-RISK IN NON-METASTATIC MEDULLOBLASTOMA: THE SIOP-EUROPE PNET4 CLINICAL TRIAL
    Clifford, Steven
    Gustafsson, Goran
    Ellison, David
    Figarella-Branger, Dominique
    Doz, Francois
    Rutkowski, Stefan
    Lannering, Birgitta
    Pietsch, Torsten
    NEURO-ONCOLOGY, 2013, 15 : 11 - 11
  • [2] IMPROVING RISK STRATIFICATION OF PATIENTS WITH NON-METASTATIC MEDULLOBLASTOMA: BIOMARKER ANALYSIS IN THE SIOP-EUROPE PNET4 CLINICAL TRIAL
    Pietsch, T.
    Gustafsson, G.
    Ellison, D.
    Figarella-Branger, D.
    Doz, F.
    Rutkowski, S.
    Lannering, B.
    Clifford, S.
    PEDIATRIC BLOOD & CANCER, 2013, 60 : 14 - 14
  • [3] Biomarker-driven stratification of disease-risk in non-metastatic medulloblastoma: Results from the multi-center HIT-SIOP-PNET4 clinical trial
    Clifford, Steven C.
    Lannering, Birgitta
    Schwalbe, Ed C.
    Hicks, Debbie
    O'Toole, Kieran
    Nicholson, Sarah Leigh
    Goschzik, Tobias
    zur Muehlen, Anja
    Figarella-Branger, Dominique
    Doz, Francois
    Rutkowski, Stefan
    Gustafsson, Goran
    Pietsch, Torsten
    ONCOTARGET, 2015, 6 (36) : 38827 - 38839
  • [4] STRATIFICATION OF CHILDREN AND ADOLESCENTS WITH MEDULLOBLASTOMA BY HISTOLOGICAL AND BIOLOGICAL PARAMETERS IN SIOP-EUROPE PNET CLINICAL TRIALS
    Clifford, S. C.
    Rutkowski, S.
    Gustafsson, G.
    Figarella-Branger, D.
    Kortmann, R. D.
    Doz, F.
    Ellison, D. W.
    Pietschs, T.
    NEURO-ONCOLOGY, 2010, 12 (06) : II6 - II6
  • [5] STRATIFICATION OF CHILDREN AND ADOLESCENTS WITH MEDULLOBLASTOMA BY HISTOLOGICAL AND BIOLOGICAL PARAMETERS IN SIOP-EUROPE PNET CLINICAL TRIALS
    Clifford, Steven
    Rutkowski, Stefan
    Gustafsson, Goran
    Figarella-Branger, Dominique
    Kortmann, Rolf
    Doz, Francois
    Lannering, Birgitta
    Ellison, David
    Pietsch, Torsten
    PEDIATRIC BLOOD & CANCER, 2010, 55 (05) : 799 - 799
  • [6] Clinical Trials in High-Risk Medulloblastoma: Evolution of the SIOP-Europe HR-MB Trial
    Bailey, Simon
    Andre, Nicolas
    Gandola, Lorenza
    Massimino, Maura
    Wheatley, Keith
    Gates, Simon
    Homer, Victoria
    Rutkowski, Stefan
    Clifford, Steven C.
    CANCERS, 2022, 14 (02)
  • [7] Pretreatment Central Quality Control for Craniospinal Irradiation and Tumorbed Boost in Non-Metastatic Medulloblastoma Treated in the SIOP PNET5 MB Trial in Germany and Switzerland
    Dietzsch, S.
    Braesigk, A.
    Seidel, C.
    Remmele, J.
    Kitzing, R.
    Schlender, T.
    Mynarek, M.
    Geismar, D.
    Jablonska, K.
    Schwarz, R.
    Pazos, M.
    Walser, M.
    Frick, S.
    Gurtner, K.
    Matuschek, C.
    Harrabi, S.
    Glueck, A.
    Lewitzki, V.
    Dieckmann, K.
    Benesch, M.
    Gerber, N.
    Rutkowski, S.
    Timmermann, B.
    Kortmann, R. -D.
    PEDIATRIC BLOOD & CANCER, 2020, 67 : S189 - S190
  • [8] Pretreatment central quality control for craniospinal irradiation in non-metastatic medulloblastoma First experiences of the German radiotherapy quality control panel in the SIOP PNET5 MB trial
    Dietzsch, Stefan
    Braesigk, Annett
    Seidel, Clemens
    Remmele, Julia
    Kitzing, Ralf
    Schlender, Tina
    Mynarek, Martin
    Geismar, Dirk
    Jablonska, Karolina
    Schwarz, Rudolf
    Pazos, Montserrat
    Walser, Marc
    Frick, Silke
    Gurtner, Kristin
    Matuschek, Christiane
    Ben Harrabi, Semi
    Gluek, Albrecht
    Lewitzki, Victor
    Dieckmann, Karin
    Benesch, Martin
    Gerber, Nicolas U.
    Rutkowski, Stefan
    Timmermann, Beate
    Kortmann, Rolf-Dieter
    STRAHLENTHERAPIE UND ONKOLOGIE, 2021, 197 (08) : 674 - 682
  • [9] NEUROPSYCHOLOGICAL OUTCOME OF CHILDREN TREATED FOR STANDARD RISK MEDULLOBLASTOMA IN THE HIT-SIOP PNET4 EUROPEAN RANDOMISED CONTROLLED TRIAL OF HYPERFRACTIONATED (HFRT) VERSUS STANDARD RADIOTHERAPY (STRT) AND MAINTENANCE CHEMOTHERAPY
    Camara-Costa, Hugo
    Resch, Anika
    Lalande, Clemence
    Kieffer, Virginie
    Poggi, Geraldina
    Kennedy, Colin
    Bull, Kim
    Calaminus, Gabriele
    Grill, Jacques
    Doz, Francois
    Rutkowski, Stefan
    Massimino, Maura
    Kortmann, Rolf-Dieter
    Lannering, Brigitta
    Dellatolas, Georges
    Chevignard, Mathilde
    NEURO-ONCOLOGY, 2014, 16 : 78 - 79
  • [10] Clinical and exploratory biomarker findings from the MODUL trial (Cohorts 1, 3 and 4) of biomarker-driven maintenance therapy for metastatic colorectal cancer
    Ducreux, Michel
    Tabernero, Josep
    Grothey, Axel
    Arnold, Dirk
    O'Dwyer, Peter J.
    Gilberg, Frank
    Abbas, Alexander
    Das Thakur, Meghna
    Prizant, Hen
    Irahara, Natsumi
    Tahiri, Anila
    Schmoll, Hans -Joachim
    Van Cutsem, Eric
    de Gramont, Aimery
    EUROPEAN JOURNAL OF CANCER, 2023, 184 : 137 - 150
12